Peter Altman
Peter Altman has made 3 open-market purchases worth $4k since Sep 24, 2026, in 1 company. The latest: $475 of BCDA, filed Oct 20, 2026, scored 26 out of 100.
President, BioCardia, Inc.
Follow Peter Altman, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 20 Form 4 (opens sec.gov) |
BCDABioCardia, Inc. · PresidentPresident · Penny stock: hard to trade | +0% stake | 26 | $475 500 at $0.95 |
— | — |
| Sep 30 Form 4 (opens sec.gov) |
BCDABioCardia, Inc. · PresidentPresident · Penny stock: hard to trade | +0% stake | 26 | $1k 1,000 at $1.03 |
— | — |
| Sep 24 Form 4 (opens sec.gov) |
BCDABioCardia, Inc. · PresidentPresident · Penny stock: hard to trade | +1% stake | 26 | $2k 1,900 at $1.05 |
— | — |
Questions
What stock has Peter Altman bought?
BCDA (BioCardia, Inc.), all on the open market and reported on SEC Form 4.
When did Peter Altman last buy?
Oct 20, 2026: 500 shares of BCDA at $0.95, $475 in all (Form 4 (opens sec.gov)).
Has Peter Altman filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Peter Altman a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 20, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer